ID27596A - Bentuk paroksetina kristal - Google Patents

Bentuk paroksetina kristal

Info

Publication number
ID27596A
ID27596A IDW20001813A ID20001813A ID27596A ID 27596 A ID27596 A ID 27596A ID W20001813 A IDW20001813 A ID W20001813A ID 20001813 A ID20001813 A ID 20001813A ID 27596 A ID27596 A ID 27596A
Authority
ID
Indonesia
Prior art keywords
paroxsetine
crystal
paroxsetine form
crystal paroxsetine
Prior art date
Application number
IDW20001813A
Other languages
English (en)
Inventor
Andrew Simon Craig
Neal Ward
Wilson Mcilwaile
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9805581.7A external-priority patent/GB9805581D0/en
Priority claimed from GBGB9813054.5A external-priority patent/GB9813054D0/en
Priority claimed from GBGB9817115.0A external-priority patent/GB9817115D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID27596A publication Critical patent/ID27596A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20001813A 1998-03-16 1999-03-16 Bentuk paroksetina kristal ID27596A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9805581.7A GB9805581D0 (en) 1998-03-16 1998-03-16 Novel compounds
GBGB9813054.5A GB9813054D0 (en) 1998-06-17 1998-06-17 Novel compounds
GBGB9817115.0A GB9817115D0 (en) 1998-08-06 1998-08-06 Novel compounds

Publications (1)

Publication Number Publication Date
ID27596A true ID27596A (id) 2001-04-12

Family

ID=27269245

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001813A ID27596A (id) 1998-03-16 1999-03-16 Bentuk paroksetina kristal

Country Status (18)

Country Link
EP (1) EP1064282A1 (id)
JP (1) JP2002506865A (id)
KR (1) KR20010041947A (id)
CN (1) CN1300286A (id)
AP (1) AP2000001907A0 (id)
AU (1) AU2847199A (id)
BG (1) BG104839A (id)
BR (1) BR9908825A (id)
CA (1) CA2323896A1 (id)
EA (1) EA200000946A1 (id)
HU (1) HUP0101215A3 (id)
ID (1) ID27596A (id)
IL (1) IL138390A0 (id)
NO (1) NO20004583L (id)
PL (1) PL342931A1 (id)
SK (1) SK13622000A3 (id)
TR (1) TR200002675T2 (id)
WO (1) WO1999047519A1 (id)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie

Also Published As

Publication number Publication date
EA200000946A1 (ru) 2001-02-26
NO20004583D0 (no) 2000-09-14
EP1064282A1 (en) 2001-01-03
BG104839A (en) 2001-09-28
PL342931A1 (en) 2001-07-16
WO1999047519A1 (en) 1999-09-23
NO20004583L (no) 2000-09-15
BR9908825A (pt) 2000-11-21
IL138390A0 (en) 2001-10-31
HUP0101215A2 (hu) 2002-04-29
SK13622000A3 (sk) 2001-03-12
AU2847199A (en) 1999-10-11
KR20010041947A (ko) 2001-05-25
CN1300286A (zh) 2001-06-20
AP2000001907A0 (en) 2000-09-30
CA2323896A1 (en) 1999-09-23
TR200002675T2 (tr) 2000-12-21
JP2002506865A (ja) 2002-03-05
HUP0101215A3 (en) 2002-05-28

Similar Documents

Publication Publication Date Title
ID25660A (id) Teripatide kristal
ID25534A (id) Glucagon-seperti kristal peptida-1
DK1062480T3 (da) Gyroskop
DK1070058T3 (da) (4-Arylsulfonylamino)-tetrahydropyran-4-carboxylsyrehydroxamider
ID26514A (id) Sumur penjernih
DK1073924T3 (da) Forstörrelsesapparat
ID23458A (id) Bentuk sediaan nefazodon
MX225999B (es) Polimorfo antifungico cristalino.
ID23287A (id) Trisiklik tersubstitusi
ID28779A (id) BENTUK-BENTUK KRISTAL DARI EtO2C-CH2-(R)CgL-Aze-Pab-OH
DE69926033D1 (de) Schlüsselkodekorrelationsanordnung
ID24221A (id) Tempat patrum
DE69839563D1 (de) Kohlenhydrat-vernetzte glykoproteinkristalle
DK1064519T3 (da) Toakset gyroskop
ID23219A (id) Trisiklik tersubstitusi
DE69913236D1 (de) Brillenbügel
DK0969233T3 (da) Strömningsbegrænser
DE69801549D1 (de) Schwalbenschwanzförmige Flüssigkristallverbindung
PT779859E (pt) Conjuntos de cristais orientados
DE59905139D1 (de) Strukturelement
DE69930205D1 (de) Kristallspaltvorrichtung
DE69710146D1 (de) Kristallhaltevorrichtung
DK1082575T3 (da) Vandfri krystaller
DE69823908D1 (de) Einkristallziehvorrichtung
NO970910D0 (no) Spirostanylglykosidal-krystaller